New managing director for Boehringer Ingelheim UK
pharmafile | January 13, 2014 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Boehringer Ingelheim, krumins
Zinta Krumins has been appointed as the managing director of Boehringer Ingelheim UK & Ireland.
The appointment will present a certain ‘déjà vu’ for Krumins, as the Bracknell-based HQ is where she first started her career with the family-owned company, as market research manager in 1989.
This is not the first time Zinta has headed up a Boehringer Ingelheim overseas operation. For six years until 2008 she was managing director of the Turkish arm of the business and, for the last 12 months, she was managing director of the Nordics.
“There is a great working environment at Boehringer Ingelheim and, although it is a very large corporation, my 25-year career path with the company is testament to the fact that it still allows people to command our own destinies,” she says.
“Having spent the last 17 years outside the UK in various different countries, I’ve thoroughly enjoyed the challenges that different management groups, different viewpoints and legislation has brought. I am delighted to now be back in the UK again, particularly at such an interesting time for our industry.”
Related Content

Boehringer Ingelheim and LEO Pharma partner to develop treatment for generalised pustular psoriasis
Boehringer Ingelheim and LEO Pharma have partnered to commercialise and further develop Spevigo (spesolimab), a …
Boehringer Ingelheim acquires Nerio Therapeutics, strengthening immune-oncology profile
Biopharmaceutical company Boehringer Ingelheim has announced the acquisition of drug discovery and development company Nerio …

Brainomix and Boehringer Ingelheim enter strategic partnership
Brainomix has announced that it has entered into a strategic partnership with Boehringer Ingelheim for …






